Ads
related to: medical, tuberculosis
Search results
Prophecy promoted by IHOPKC founder is based on incorrect information, document shows
Kansas City Star via Yahoo News· 6 days ago“He has video of him telling this story brazenly over and over ... And it was so compelling and so...
King County health officer retires after 30-plus years in public health
Seattle Times· 2 days agoDr. Jeff Duchin is accustomed to 100-mile bike rides through the Pacific Northwest mountains, beside...
Asthma, COPD often not diagnosed, study indicates
UPI· 2 days agoFinding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease improved their health and led to fewer appointments for...
How biologics can help with symptoms of Crohn's
Medical News Today· 4 days agoBiologic therapies for Crohn’s disease (CD) do more than reduce the common symptoms of diarrhea, abdominal cramping, and pain. CD and ulcerative colitis...
TB has reclaimed its place as the world’s biggest infectious killer – but are its days numbered?
Daily Telegraph· 2 days agoAs patients’ immune systems were weakened by the new disease, there was a surge in TB. HIV caused 55...
CDC unveils dashboard to track bird flu as virus spreads among dairy farms
USA Today· 5 days agoThe CDC has released a new dashboard to track the spread of bird flu. The dashboard includes data on...
Trends in Nationally Notifiable Infectious Diseases in Humans and Animals during COVID-19 Pandemic,...
Centers for Disease Control and Prevention· 5 days agoTrends in Notifiable Diseases during COVID-19
More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved...
WTRF Wheeling· 8 hours agoIn Eli Lilly and Company's (NYSE: LLY) pivotal Phase 3 VIVID-1 study, patients with moderately to severely active Crohn's disease, with or without previous biologic failure, achieved statistically ...
California bill targets 'Sephora kids' with skincare ban for children younger than 13
USA Today· 6 days agoA bill under consideration in California would ban selling certain anti-aging skincare products to...
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 1 day agoWASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...
